News

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...
The drugmaker has invested $10 billion in Wake and Durham counties over the past 30 years. Biogen says that figure will ...
President Donald Trump has threatened tariffs on drugs coming from overseas, but it might take more than that to reroute the ...
Targeting European allies won't fix any of our problems with China, or improve health care, writes Josh Steuterman.
President Trump’s threat to impose 30% tariffs on the European Union disrupted negotiations. From cars to wine, these are the ...
Find insight on European pharmaceutical sector corporate bonds, GSK and more in the latest Market Talks covering Health Care.
The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...
Finally, don't discount legal challenges to the president's tariffs. An argument could be made that pharmaceutical products ...
That's the total value of pharmaceuticals China imported last year, up from $27 billion in 2017. Despite Beijing's drive for economic self-sufficiency, it has continued to welcome U.S. medical ...
W hen Donald Trump’s tariffs are mentioned, you might recall his “Liberation Day” duties on uninhabited islands, his on-again ...
J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...
President Donald Trump said he will most likely impose tariffs on pharmaceuticals as soon as the end of the month, along with tariffs on semiconductors, Bloomberg reported July 15. Here are four notes ...